Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What are Cells?01:07

What are Cells?

199.2K
Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
199.2K
C4 Pathway and CAM01:27

C4 Pathway and CAM

49.1K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.1K
What is a Nervous System?01:25

What is a Nervous System?

104.6K
Overview
104.6K
Gustation01:43

Gustation

52.3K
Gustation is a chemical sense that, along with olfaction (smell), contributes to our perception of taste. It starts with the activation of receptors by chemical compounds (tastants) dissolved in the saliva. The saliva and filiform papillae on the tongue distribute the tastants and increase their exposure to the taste receptors.
52.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Middle Meningeal Artery Embolization With n-Butyl Cyanoacrylate in Patients With Chronic Subdural Hematoma: A Randomized Clinical Trial.

JAMA neurology·2026
Same author

Identifying social determinants of health subgroups and their associations with health outcomes in a prospective US adult COVID-19 cohort: an analysis of the INSPIRE registry.

BMJ open·2026
Same author

Seasonality, Hospitalization, and Initiation of Home Dialysis: A Retrospective Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Clinical and Angiographic Outcomes in Patients With Tandem Occlusion Thrombectomy: Analysis From the ASSIST International Registry.

Stroke (Hoboken, N.J.)·2026
Same author

A Prospective, Multicenter, Open-Label Assessment of Efficacy and Safety of the Quanta Dialysis System for Home Hemodialysis.

Kidney medicine·2026
Same author

How Do We Boost Home Dialysis?

JAMA network open·2026

Related Experiment Video

Updated: Jan 31, 2026

Directly Measuring Forces Within Reconstituted Active Microtubule Bundles
07:47

Directly Measuring Forces Within Reconstituted Active Microtubule Bundles

Published on: May 10, 2022

2.0K

Calcimimetics and Bundled Reimbursement.

Eugene Lin1, Suzanne Watnick2

  • 1Division of Nephrology and Hypertension, Department of Medicine, University of Southern California, Los Angeles, CA; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA; Kidney Research Center, University of Southern California/University Kidney Research Organization, Los Angeles, CA.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|January 7, 2019
PubMed
Summary

Medicare

Keywords:
EtelcalcetideProspective Payment System (PPS)bone-mineral metabolismbundlecalcimimeticdialysis clinicdrug costsend-stage renal disease (ESRD)health care incentivehemodialysismedical parathyroidectomyparathyroid hormone (PTH)paymentreimbursement ratetransition

More Related Videos

Stereocilia Bundle Imaging with Nanoscale Resolution in Live Mammalian Auditory Hair Cells
06:47

Stereocilia Bundle Imaging with Nanoscale Resolution in Live Mammalian Auditory Hair Cells

Published on: January 21, 2021

3.6K
Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
06:53

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers

Published on: May 4, 2022

2.6K

Related Experiment Videos

Last Updated: Jan 31, 2026

Directly Measuring Forces Within Reconstituted Active Microtubule Bundles
07:47

Directly Measuring Forces Within Reconstituted Active Microtubule Bundles

Published on: May 10, 2022

2.0K
Stereocilia Bundle Imaging with Nanoscale Resolution in Live Mammalian Auditory Hair Cells
06:47

Stereocilia Bundle Imaging with Nanoscale Resolution in Live Mammalian Auditory Hair Cells

Published on: January 21, 2021

3.6K
Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
06:53

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers

Published on: May 4, 2022

2.6K

Area of Science:

  • Nephrology
  • Health Economics

Background:

  • Medicare's Prospective Payment System bundles dialysis services.
  • Oral-only medications are currently excluded from the dialysis bundle.
  • Injectable calcimimetics, like etelcalcetide, are transitioning into the bundle.

Purpose of the Study:

  • To analyze the implications of incorporating injectable calcimimetics into the Medicare dialysis bundle.
  • To predict potential impacts on calcimimetic use and patient care.
  • To highlight the need for careful implementation and monitoring.

Main Methods:

  • Analysis of Medicare reimbursement policies for renal dialysis.
  • Review of the transition payment for etelcalcetide.
  • Assessment of potential provider incentives and financial ramifications.

Main Results:

  • Injectable calcimimetics will be incorporated into the dialysis bundle after a transition period.
  • Providers may be incentivized to reduce calcimimetic use post-transition.
  • The financial impact on dialysis organizations and patient health is uncertain.

Conclusions:

  • Careful incorporation of calcimimetics into the dialysis bundle is critical.
  • Close monitoring of patient outcomes is essential to mitigate adverse effects.
  • Evidence-based guidelines are needed for bone-mineral management in dialysis patients.